Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: Imaging and local therapy

Breast Cancer Research and Treatment

Volumn 120, Issue 2, 2010, Pages 273-284

  Sparano, Joseph A ^a   Pisano, Etta D ^b   White, Julia R ^c   Hunt, Kelly K ^d   Mamounas, Eleftherios P ^e   Perez, Edith A ^f   Hortobagyi, Gabriel N ^d   Gralow, Julie R ^g   Comis, Robert L ^h  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e AULTMAN HOSPITAL   (United States)

^f MAYO CLINIC   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^h Coalition of Cancer Cooperative Groups ^*  (United States)

Author keywords

Breast cancer; Imaging; Radiation therapy local therapy

Indexed keywords

ANASTROZOLE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; EXEMESTANE; FLUOROURACIL; LAPATINIB; LETROZOLE; PACLITAXEL; TRASTUZUMAB;

BRACHYTHERAPY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SCREENING; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONTRAST ENHANCEMENT; CRYOABLATION; CYTOREDUCTIVE SURGERY; DIAGNOSTIC ACCURACY; DIGITAL MAMMOGRAPHY; DRUG EFFICACY; EARLY DIAGNOSIS; ECHOMAMMOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; FEASIBILITY STUDY; HIGH RISK POPULATION; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAMMOGRAPHY; MASTECTOMY; MEDICAL SOCIETY; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; PATIENT SAFETY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; RESEARCH;

EID: 77950689917     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0655-z     Document Type: Review

References (80)

1. American Cancer Society (2007) Breast cancer facts and figures 2007-2008. American Cancer Society, Inc, Atlanta
2. Stewart SL, King JB, Thompson TD et al (2004) Cancer mortality surveillance- United States, 1990-2000. MMWR Surveill Summ 53:1-108
3. 3. Berry DA, Cronin KA, Plevritis SK et al (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353:1784-1792 (Pubitemid 41549890)
4. 4. Ravdin PM, Cronin KA, Howlader N et al (2007) The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356:1670-1674 (Pubitemid 46631679)
5. Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 288:321-333
6. Jemal A, Siegel R, Ward E et al (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225-249
7. Sparano JA, Hortobagyi GN, Gralow JR, Perez EA, Comis RL (2009) Recommendations for research priorities in breast cancer by the coalition of Cancer Cooperative Groups Scientific Leadership Council: systemic therapy and therapeutic individualization. Breast Cancer Res Treat. doi:10.1007/sI0549-009- 0433-y
8. Kerlikowske K, Grady D, Rubin SM et al (1995) Efficacy of screening mammography. A meta-analysis. JAMA 273:149-154
9. Hendrick RE, Smith RA, Rutledge JH III et al (1997) Benefit of screening mammography in women aged 40-49: a new metaanalysis of randomized controlled trials. J Natl Cancer Inst Monogr 22:87-92
10. Kopans DB (2003) Mammographic screening for breast cancer. N Engl J Med 349:610-612 (author reply 610-612)
11. Kopans DB, Feig SA (1998) False positive rate of screening mammography. N Engl J Med 339:562-564
12. Centers for Disease Control, Prevention (2007) Use of mammograms among women aged > or = 40 years- United States 2000-2005. MMWR Morb Mortal Wkly Rep 56:49-51
13. Joy JE, Penhoet EE, Petitti DB (eds) (2004) Saving women's lives: strategies for improving breast cancer detection and diagnosis. The National Academies Press, Washington, DC
14. Pisano ED, Yaffe MJ (2005) Digital mammography. Radiology 234:353-362
15. Pisano ED, Acharyya S, Cole EB et al (2009) Cancer cases from ACRIN digital mammographic imaging screening trial: radiologist analysis with use of a logistic regression model. Radiology 252:348-357
16. 16. Pisano ED, Gatsonis C, Hendrick E et al (2005) Diagnostic performance of digital versus film mammography for breastcancer screening. N Engl J Med 353:1773-1783 (Pubitemid 41549889)
17. 17. Tosteson AN, Stout NK, Fryback DG et al (2008) Cost-effectiveness of digital mammography breast cancer screening. Ann Intern Med 148:1-10 (Pubitemid 351664941)
18. 18. Jong RA, Yaffe MJ, Skarpathiotakis M et al (2003) Contrastenhanced digital mammography: initial clinical experience. Radiology 228:842-850 (Pubitemid 37025497)
19. 19. Buchberger W, DeKoekkoek-Doll P, Springer P et al (1999) Incidental findings on sonography of the breast: clinical significance and diagnostic workup. AJR Am J Roentgenol 173:921-927 (Pubitemid 29451285)
20. Kaplan SS (2001) Clinical utility of bilateral whole-breast US in the evaluation of women with dense breast tissue. Radiology 221:641-649
21. KoIb TM, Lichy J, Newhouse JH (2002) Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them.: an analysis of 27, 825 patient evaluations. Radiology 225:165-175
22. Lehman CD, Isaacs C, Schnall MD et al (2007) Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology 244:381-388
23. 23. Warner E, Plewes DB, Hill KA et al (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292:1317-1325 (Pubitemid 39223222)
24. 24. Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, Böhm-Vélez M, Pisano ED, Jong RA, Evans WP, Morton MJ, Mahoney MC, Larsen LH, Barr RG, Farria DM, Marques HS, Boparai K, ACRIN 6666 Investigators (2008) Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 299(18):2151-2163 (Pubitemid 351679706)
25. Berg W (2007) Yield of screening breast ultrasound and mammography compared to mammography alone: results of first screen in ACRIN (American College of Radiology Imaging Network, the Radiological Society of North America (RSNA) 93rd Scientific Assembly and Annual Meeting. Chicago, Illinois
26. Berg W (2007) Risk of false positives with supplemental screening breast US: results from the first screen in the ACRIN (American College of Radiology Imaging Network), the Radiological Society of North America (RSNA) 93rd Scientific Assembly and Annual Meeting. Chicago, Illinois
27. Kriege M, Brekelmans CT, Boetes C et al (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427-437
28. 28. Brekelmans CT, Seynaeve C, Bartels CC et al (2001) Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 19:924- 930 (Pubitemid 32176266)
29. Chart PL, Franssen E (1997) Management of women at increased risk for breast cancer: preliminary results from a new program. CMAJ 157:1235-1242
30. 30. Lalloo F, Boggis CR, Evans DG et al (1998) Screening by mammography, women with a family history of breast cancer. Eur J Cancer 34:937-940 (Pubitemid 28248511)
31. Kuhl CK, Schrading S, Wardelmann E et al (2007) Magnetic resonance imaging versus mammography for diagnosing ductal carcinoma in situ. J Clin Oncol 25:1504 (suppl; abstr 1504)
32. 32. Lord SJ, Lei W, Craft P et al (2007) A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer 43:1905-1917 (Pubitemid 47299201)
33. 33. Lehman CD, Gatsonis C, Kuhl CK et al (2007) MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356:1295-1303 (Pubitemid 46513295)
34. 34. Saslow D, Boetes C, Burke W et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75-89 (Pubitemid 46535708)
35. Turtle TM, Habermann EB, Grund EH et al (2007) Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol 25:5203-5209
36. Turtle TM, Jarosek S, Habermann EB et al (2009) Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol 27:1362-1367
37. Katipamula R, Degnim AC, Hoskin T et al (2009) Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 27:4082-4088
38. Solin LJ, Orel SG, Hwang WT et al (2008) Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 26:386-391
39. Bleicher RJ, Ciocca RM, Egleston BL et al (2009) Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg 209:180-187 (quiz 294-295)
40. 40. Berg WA, Weinberg IN, Narayanan D et al (2006) High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer. Breast J 12:309-323 (Pubitemid 43989975)
41. 41. Poplack SP, Tosteson TD, Kogel CA et al (2007) Digital breast tomosynthesis: initial experience in 98 women with abnormal digital screening mammography. AJR Am J Roentgenol 189:616-623 (Pubitemid 47328544)
42. Vazquez B, Rousseau D, Hurd TC (2007) Surgical management of breast cancer. Semin Oncol 34:234-240
43. Morrow M (2007) Improved survival in metastatic breast cancer following total excision of the primary tumor. Nat Clin Pract Oncol 4(1):14-15
44. Lee MC, Newman LA (2007) Management of patients with locally advanced breast cancer. Surg Clin North Am 87:379-398 (ix)
45. Haka AS, Volynskaya Z, Gardecki JA et al (2006) In vivo margin assessment during partial mastectomy breast surgery using Raman spectroscopy. Cancer Res 66:3317-3322
46. Bickford LR, Agollah G, Drezek R, Yu TK (2009) Silica-gold nanoshells as potential intraoperative molecular probes for HER2-overexpression in ex vivo breast tissue using near-infrared reflectance confocal microscopy. Breast Cancer Res Treat, doi: 10.1007/S10549-009-0408-Z
47. Singletary SE, Fornage BD, Sneige N et al (2002) Radiofrequency ablation of early-stage invasive breast tumors: an overview. Cancer J 8:177-180
48. Waljee JF, Newman LA (2007) Neoadjuvant systemic therapy and the surgical management of breast cancer, Surg Clin North Am 87:399-415 (ix)
49. 49. Oh JL, Nguyen G, Whitman GJ et al (2007) Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy. Cancer 110:2420-2427 (Pubitemid 350174926)
50. 50. Albertini JJ, Lyman GH, Cox C et al (1996) Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276:1818-1822 (Pubitemid 26406231)
51. 51. Bedrosian I, Reynolds C, Mick R et al (2000) Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 88:2540-2545 (Pubitemid 30331961)
52. Giuliano AE, Kirgan DM, Guenther JM et al (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-398 (discussion 398-401)
53. Krag DN, Julian TB, Harlow SP et al (2004) NSABP-32: phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: a description of the trial. Ann Surg Oncol 11:208S-210S
54. McMasters KM, Turtle TM, Carlson DJ et al (2000) Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 18:2560-2566
55. O'Hea BJ, Hill AD, El-Shirbiny AM et al (1998) Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 186:423-427
56. 56. Wong SL, Edwards MJ, Chao C et al (2002) The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol 9:272-277 (Pubitemid 34298632)
57. Newman LA, Mamounas EP (2007) Review of breast cancer clinical trials conducted by the National Surgical Adjuvant Breast Project. Surg Clin North Am 87:279-305 (vii)
58. 58. Creager AJ, Geisinger KR, Perrier ND et al (2004) Intraoperative imprint cytologic evaluation of sentinel lymph nodes for lobular carcinoma of the breast. Ann Surg 239:61-66 (Pubitemid 38176373)
59. 59. Shiver SA, Creager AJ, Geisinger K et al (2002) Intraoperative analysis of sentinel lymph nodes by imprint cytology for cancer of the breast. Am J Surg 184:424-427 (Pubitemid 35335949)
60. Creager AJ, Geisinger KR, Shiver SA et al (2002) Intraoperative evaluation of sentinel lymph nodes for metastatic breast carcinoma by imprint cytology. Mod Pathol 15:1140-1147
61. 61. Blumencranz P, Whitworth PW, Deck K et al (2007) Scientific Impact Recognition Award. Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors. Am J Surg 194:426-432 (Pubitemid 47370997)
62. 62. Mamounas EP (2003) Sentinel lymph node biopsy after neoadjuvant systemic therapy. Surg Clin North Am 83:931-942 (Pubitemid 36841917)
63. Xing Y, Foy M, Cox DD et al (2006) Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 93:539-546
64. 64. Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087-2106 (Pubitemid 41797643)
65. 65. Part DA, Goodwin JS, Kuo YF et al (2005) Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol 23:7475-7482 (Pubitemid 46291810)
66. 66. Giordano SH, Kuo YF, Freeman JL et al (2005) Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 97:419-424 (Pubitemid 40528604)
67. 67. Sanders ME, Scroggins T, Ampil FL et al (2007) Accelerated partial breast irradiation in early-stage breast cancer. J Clin Oncol 25:996-1002 (Pubitemid 350002866)
68. Fearmonti RM, Vicini FA, Pawlik TM et al (2007) Integrating partial breast irradiation into surgical practice and clinical trials. Surg Clin North Am 87:485-498 (x-xi)
69. Arthur DW, Winter K, Kuske RR et al (2008) A phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of Rtog 95-17. Int J Radiat Oncol Biol Phys 72:467-473
70. 70. Vicini FA, Chen P, Wallace M et al (2007) Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiât Oncol Biol Phys 69:1124-1130 (Pubitemid 47625835)
71. 71. Benitez PR, Keisch ME, Vicini F et al (2007) Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg 194:456-462 (Pubitemid 47370993)
72. 72. Keisch M, Vicini F (2005) Applying innovations in surgical and radiation oncology to breast conservation therapy. Breast J 11(suppl 1.):S24-S29 (Pubitemid 40444580)
73. 73. Donovan E, Bleakley N, Denholm E et al (2007) Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 82:254-264 (Pubitemid 46341474)
74. Pignol JP, Olivotto I, Rakovitch E et al (2008) A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 26:2085-2092
75. 75. Harsolia A, Kestin L, Grills I et al (2007) Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. Int J Radiat Oncol Biol Phys 68:1375-1380 (Pubitemid 47176804)
76. Bentzen SM, Agrawal RK, Aird EG et al (2008) The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 371:1098-1107
77. 77. Whelan T, MacKenzie R, Julian J et al (2002) Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 94:1143- 1150 (Pubitemid 34919051)
78. Freedman GM, Anderson PR, Goldstein LJ et al (2007) Fourweek course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost. Int J Radiat Oncol Biol Phys 68:347-353
79. 79. Formenti SC, Gidea-Addeo D, Goldberg JD et al (2007) Phase III trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. J Clin Oncol 25:2236-2242 (Pubitemid 46954649)
80. Jin JY, Klein EE, Kong FM et al (2005) An improved internal mammary irradiation technique in radiation treatment of locally advanced breast cancers. J Appl Clin Med Phys 6:84-93